Follow
Peter van den Elzen
Peter van den Elzen
Verified email at mail.ubc.ca
Title
Cited by
Cited by
Year
Apolipoprotein-mediated pathways of lipid antigen presentation
P Elzen, S Garg, L León, M Brigl, EA Leadbetter, JE Gumperz, ...
Nature 437 (7060), 906-910, 2005
4482005
Influenza infection in suckling mice expands an NKT cell subset that protects against airway hyperreactivity
YJ Chang, HY Kim, LA Albacker, HH Lee, N Baumgarth, S Akira, ...
The Journal of clinical investigation 121 (1), 57-69, 2011
1792011
Conserved and heterogeneous lipid antigen specificities of CD1d-restricted NKT cell receptors
M Brigl, P van den Elzen, X Chen, JH Meyers, D Wu, CH Wong, ...
The Journal of Immunology 176 (6), 3625-3634, 2006
1142006
Innate immune control of EBV-infected B cells by invariant natural killer T cells
BK Chung, K Tsai, LL Allan, DJ Zheng, JC Nie, CM Biggs, MR Hasan, ...
Blood, The Journal of the American Society of Hematology 122 (15), 2600-2608, 2013
1062013
Apolipoprotein-mediated lipid antigen presentation in B cells provides a pathway for innate help by NKT cells
LL Allan, K Hoefl, DJ Zheng, BK Chung, FK Kozak, R Tan, ...
Blood, The Journal of the American Society of Hematology 114 (12), 2411-2416, 2009
932009
A public T cell clonotype within a heterogeneous autoreactive repertoire is dominant in driving EAE
JS Menezes, P van den Elzen, J Thornes, D Huffman, NM Droin, ...
The Journal of clinical investigation 117 (8), 2176-2185, 2007
712007
CD1d and CD1c expression in human B cells is regulated by activation and retinoic acid receptor signaling
LL Allan, AM Stax, DJ Zheng, BK Chung, FK Kozak, R Tan, ...
The Journal of Immunology 186 (9), 5261-5272, 2011
702011
Self-reactive T cells and degeneracy of T cell recognition: evolving concepts—from sequence homology to shape mimicry and TCR flexibility
E Maverakis, P van den Elzen, EE Sercarz
Journal of Autoimmunity 16 (3), 201-209, 2001
622001
Differential expression of T-bet, a T-box transcription factor required for Th1 T-cell development, in peripheral T-cell lymphomas
DM Dorfman, P van den Elzen, AP Weng, A Shahsafaei, LH Glimcher
American journal of clinical pathology 120 (6), 866-873, 2003
582003
Molecular characterization of the T cell repertoire using immuno-scope analysis and its possible implementation in clinical practice
F Ria, P Elzen, LT Madakamutil, JE Miller, E Maverakis, EE Sercarz
Current molecular medicine 1 (3), 297-304, 2001
572001
CD1 assembly and the formation of CD1–antigen complexes
DL Hava, M Brigl, P van den Elzen, DM Zajonc, IA Wilson, MB Brenner
Current opinion in immunology 17 (1), 88-94, 2005
512005
Autoreactive T cells can be protected from tolerance induction through competition by flanking determinants for access to class II MHC
E Maverakis, J Beech, DB Stevens, A Ametani, L Brossay, ...
Proceedings of the National Academy of Sciences 100 (9), 5342-5347, 2003
362003
NKT cells are required for complete Freund’s adjuvant-mediated protection from autoimmune diabetes
I Lee, P van den Elzen, R Tan, JJ Priatel
The Journal of Immunology 187 (6), 2898-2904, 2011
242011
Autoreactivity to sulfatide by human invariant NKT cells
AM Stax, J Tuengel, E Girardi, N Kitano, LL Allan, V Liu, D Zheng, ...
The Journal of Immunology 199 (1), 97-106, 2017
232017
Administration of PLP139–151 primes T cells distinct from those spontaneously responsive in vitro to this antigen
R Penitente, C Nicolo, P Van den Elzen, G Di Sante, C Agrati, F Aloisi, ...
The Journal of Immunology 180 (10), 6611-6622, 2008
232008
Activation of invariant natural killer T cells stimulated with microbial α-mannosyl glycolipids
M Shimamura, M Yamamura, T Nabeshima, N Kitano, P van den Elzen, ...
Scientific reports 7 (1), 9703, 2017
212017
Limited clonality in autoimmunity: drivers and regulators
P Van Den Elzen, JS Menezes, A Ametani, E Maverakis, L Madakamutil, ...
Autoimmunity Reviews 3 (7-8), 524-529, 2004
202004
Seven Surprises in the TCR‐Centred Regulation of Immune Responsiveness in an Autoimmune System
E Sercarz, E Maverakis, P van den Elzen, L Madakamutil, V Kumar
Generation and Effector Functions of Regulatory Lymphocytes: Novartis …, 2003
142003
Residual public repertoires to self
SS Wilson, P van den Elzen, E Maverakis, JT Beech, TA Braciak, V Kumar, ...
Journal of neuroimmunology 107 (2), 233-239, 2000
112000
Acidification‐dependent activation of CD1d‐restricted natural killer T cells is intact in cystic fibrosis
SE Rzemieniak, AF Hirschfeld, RE Victor, MA Chilvers, D Zheng, ...
Immunology 130 (2), 288-295, 2010
92010
The system can't perform the operation now. Try again later.
Articles 1–20